News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
India’s Strides Arcolab Limited Gets US Nod For HIV Tab Nevirapine
August 16, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MUMBAI, Aug 16 (Reuters) - India's Strides Arcolab Ltd. (STAR.BO: Quote, Profile, Research) said on Wednesday it had received tentative approval from the U.S. Food and Drug Administration for its HIV drug nevirapine in tablet forms.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Asia
MORE ON THIS TOPIC
Manufacturing
With onshoring ‘having a moment,’ Aquestive CEO shares lessons from 20 years of US manufacturing
June 23, 2026
·
4 min read
·
Nick Paul Taylor
Deals
Nuvectis, Haisco ink up to $1.4B deal for two late-stage programs
June 22, 2026
·
2 min read
·
Gabrielle Masson
Policy
HHS debuts ‘unprecedented’ initiative to ‘restore American leadership’ in clinical trials
June 22, 2026
·
3 min read
·
Heather McKenzie
FDA
REGENXBIO to resubmit application for Hunter gene therapy after FDA’s most recent pivot
June 22, 2026
·
3 min read
·
Heather McKenzie
